ALG6 Activators
ALG6 activators belong to a specialized class of chemical compounds that have gained significance in the field of molecular biology and cellular processes. These compounds are carefully designed to modulate the activity of ALG6, a protein-coding gene with crucial roles in various cellular functions. ALG6, or Asparagine-Linked Glycosylation 6, is an essential component of the endoplasmic reticulum-associated glycosylation (ERAG) pathway, responsible for the attachment of glycans to proteins during their synthesis. ALG6 activators function by targeting specific regulatory elements within the ALG6 gene, often located in promoter or enhancer regions, with the primary aim of enhancing its transcription and subsequent translation into functional protein products.
The mechanisms through which ALG6 activators exert their effects may vary, but their central purpose is to act as molecular switches, amplifying the activity of ALG6. Researchers are continually exploring the potential applications and implications of ALG6 activation, aiming to deepen our understanding of how this gene contributes to cellular processes, particularly within the context of protein glycosylation and quality control. This class of compounds holds promise for advancing our knowledge of glycosylation pathways, specifically within the realm of the ERAG pathway and its roles in ensuring proper protein folding and function. ALG6 activators serve as valuable tools in the ongoing exploration of molecular biology, providing opportunities to uncover the complex roles that ALG6 plays in cellular functions and its potential impact on protein glycosylation and processing.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which may upregulate ALG6 expression as a compensatory response to maintain glycosylation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts ER to Golgi traffic, potentially upregulating ALG6 as part of a stress response to restore protein trafficking. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
This chemical chaperone may upregulate ALG6 expression to assist in protein folding and trafficking within cells. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $135.00 $540.00 $1025.00 $6248.00 | 25 | |
Kifunensine inhibits mannose trimming in N-glycans, which may induce a cellular response increasing ALG6 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin induces ER stress by depleting calcium stores, possibly leading to increased expression of ALG6. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea causes replication stress and DNA damage response, which might incidentally upregulate ALG6 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine disrupts lysosomal function, which may affect glycosylation pathways and ALG6 expression indirectly. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid induces ER stress and can modulate UPR signaling, potentially affecting ALG6 expression. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Phenylarsine oxide inhibits disulfide bond formation, causing protein misfolding and potential upregulation of ALG6. | ||||||